Ritholtz Wealth Management Makes New $488,000 Investment in Electromed, Inc. (NYSE:ELMD)

Ritholtz Wealth Management acquired a new position in shares of Electromed, Inc. (NYSE:ELMD - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 16,504 shares of the company's stock, valued at approximately $488,000. Ritholtz Wealth Management owned approximately 0.20% of Electromed at the end of the most recent reporting period.

Several other institutional investors have also recently modified their holdings of ELMD. Navellier & Associates Inc. purchased a new stake in Electromed in the 3rd quarter worth approximately $368,000. State Street Corp increased its stake in Electromed by 14.5% in the third quarter. State Street Corp now owns 22,066 shares of the company's stock valued at $474,000 after purchasing an additional 2,800 shares during the last quarter. Barclays PLC purchased a new position in Electromed during the third quarter worth about $215,000. Walleye Capital LLC purchased a new stake in Electromed in the 3rd quarter valued at about $274,000. Finally, Legacy Wealth Asset Management LLC acquired a new position in shares of Electromed during the 4th quarter valued at about $253,000. 40.82% of the stock is currently owned by institutional investors and hedge funds.

Electromed Stock Up 0.5 %

Shares of Electromed stock traded up $0.18 during trading hours on Tuesday, hitting $34.18. The company's stock had a trading volume of 108,135 shares, compared to its average volume of 96,890. Electromed, Inc. has a 1-year low of $9.90 and a 1-year high of $35.07. The company has a market capitalization of $289.12 million, a PE ratio of 47.41 and a beta of 0.31. The business has a fifty day moving average of $29.72 and a 200 day moving average of $22.46.

Electromed (NYSE:ELMD - Get Free Report) last posted its earnings results on Tuesday, November 12th. The company reported $0.16 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.03 by $0.13. The business had revenue of $14.67 million during the quarter. Electromed had a return on equity of 15.32% and a net margin of 11.34%.

Analysts Set New Price Targets

Separately, StockNews.com cut shares of Electromed from a "strong-buy" rating to a "buy" rating in a research note on Thursday, January 9th.

Insider Buying and Selling

In other Electromed news, Director Andrew Summers sold 12,731 shares of the business's stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $29.98, for a total transaction of $381,675.38. Following the completion of the transaction, the director now directly owns 165,755 shares of the company's stock, valued at $4,969,334.90. The trade was a 7.13 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 14.00% of the company's stock.

Electromed Company Profile

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.